138 related articles for article (PubMed ID: 15527859)
1. Emergence of attenuated West Nile virus variants in Texas, 2003.
Davis CT; Beasley DW; Guzman H; Siirin M; Parsons RE; Tesh RB; Barrett AD
Virology; 2004 Dec; 330(1):342-50. PubMed ID: 15527859
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.
Wicker JA; Whiteman MC; Beasley DW; Davis CT; Zhang S; Schneider BS; Higgs S; Kinney RM; Barrett AD
Virology; 2006 Jun; 349(2):245-53. PubMed ID: 16624366
[TBL] [Abstract][Full Text] [Related]
3. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.
Lee E; Hall RA; Lobigs M
J Virol; 2004 Aug; 78(15):8271-80. PubMed ID: 15254199
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
5. Fine-scale genetic variation and evolution of West Nile Virus in a transmission "hot spot" in suburban Chicago, USA.
Bertolotti L; Kitron UD; Walker ED; Ruiz MO; Brawn JD; Loss SR; Hamer GL; Goldberg TL
Virology; 2008 May; 374(2):381-9. PubMed ID: 18261758
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of West Nile virus isolates from US blood donors during 2002-2005.
Tang Y; Liu B; Hapip CA; Xu D; Fang CT
J Clin Virol; 2008 Nov; 43(3):292-7. PubMed ID: 18818120
[TBL] [Abstract][Full Text] [Related]
7. Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype.
Davis CT; Ebel GD; Lanciotti RS; Brault AC; Guzman H; Siirin M; Lambert A; Parsons RE; Beasley DW; Novak RJ; Elizondo-Quiroga D; Green EN; Young DS; Stark LM; Drebot MA; Artsob H; Tesh RB; Kramer LD; Barrett AD
Virology; 2005 Nov; 342(2):252-65. PubMed ID: 16137736
[TBL] [Abstract][Full Text] [Related]
8. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.
Rossi SL; Zhao Q; O'Donnell VK; Mason PW
Virology; 2005 Jan; 331(2):457-70. PubMed ID: 15629788
[TBL] [Abstract][Full Text] [Related]
9. Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.
Anthony KG; Bai F; Krishnan MN; Fikrig E; Koski RA
Antiviral Res; 2009 Jun; 82(3):166-8. PubMed ID: 19135091
[TBL] [Abstract][Full Text] [Related]
10. Variation in virulence of West Nile virus strains for house sparrows (Passer domesticus).
Langevin SA; Brault AC; Panella NA; Bowen RA; Komar N
Am J Trop Med Hyg; 2005 Jan; 72(1):99-102. PubMed ID: 15728874
[TBL] [Abstract][Full Text] [Related]
11. Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations.
Yu L; Robert Putnak J; Pletnev AG; Markoff L
Vaccine; 2008 Nov; 26(47):5981-8. PubMed ID: 18805457
[TBL] [Abstract][Full Text] [Related]
12. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines.
Fayzulin R; Scholle F; Petrakova O; Frolov I; Mason PW
Virology; 2006 Jul; 351(1):196-209. PubMed ID: 16647099
[TBL] [Abstract][Full Text] [Related]
14. Multiple pathways to the attenuation of West Nile virus in south-east Texas in 2003.
May FJ; Li L; Davis CT; Galbraith SE; Barrett AD
Virology; 2010 Sep; 405(1):8-14. PubMed ID: 20580395
[TBL] [Abstract][Full Text] [Related]
15. Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication.
Ong SP; Choo BG; Chu JJ; Ng ML
Antiviral Res; 2006 Dec; 72(3):216-23. PubMed ID: 16870272
[TBL] [Abstract][Full Text] [Related]
16. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.
Chang GJ; Davis BS; Stringfield C; Lutz C
Vaccine; 2007 Mar; 25(12):2325-30. PubMed ID: 17224209
[TBL] [Abstract][Full Text] [Related]
17. A combination of naturally occurring mutations in North American West Nile virus nonstructural protein genes and in the 3' untranslated region alters virus phenotype.
Davis CT; Galbraith SE; Zhang S; Whiteman MC; Li L; Kinney RM; Barrett AD
J Virol; 2007 Jun; 81(11):6111-6. PubMed ID: 17376926
[TBL] [Abstract][Full Text] [Related]
18. The Israeli strain IS-98-ST1 of West Nile virus as viral model for West Nile encephalitis in the Old World.
Lucas M; Frenkiel MP; Mashimo T; Guénet JL; Deubel V; Desprès P; Ceccaldi PE
Virol J; 2004 Nov; 1():9. PubMed ID: 15550172
[TBL] [Abstract][Full Text] [Related]
19. A sensitive cell-based assay for the detection of residual infectious West Nile virus.
Koldijk MH; Bogaards JA; Kostense S; de Vocht M; Gijsbers L; Ter Haak M; Ophorst C; Brakenhoff JP; Weverling GJ; Guichoux JY; Uytdehaag F; Lewis J; Goudsmit J; Marzio G
Vaccine; 2007 Sep; 25(39-40):6872-81. PubMed ID: 17707954
[TBL] [Abstract][Full Text] [Related]
20. Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness.
Whiteman MC; Wicker JA; Kinney RM; Huang CY; Solomon T; Barrett AD
Vaccine; 2011 Dec; 29(52):9702-10. PubMed ID: 21945257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
